ACAD
39.13
+0.99
+2.60%
AEMD
0.23
+0.02
+8.47%
APRI
2.47
-0.03
-1.04%
ARNA
4.24
-0.08
-1.85%
ATEC
1.5
0.00
0.00%
CFN
60.37
+0.12
+0.20%
CNAT
6.57
+0.27
+4.29%
CRXM
0.2
+0.00
+0.30%
CYTX
1.14
-0.01
-0.44%
DXCM
60.45
+0.57
+0.95%
GNMK
12.84
+0.26
+2.07%
HALO
15.35
-0.35
-2.23%
ILMN
200.04
+7.36
+3.82%
INNV
0.16
0.00
-2.42%
INO
7.57
+0.21
+2.85%
ISCO
0.06
+0.00
+5.93%
ISIS
71.71
+1.55
+2.21%
LGND
69.19
+1.64
+2.43%
LPTN
2.9
-0.03
-1.02%
MBVX
0.91
-0.15
-14.15%
MEIP
5.73
+0.23
+4.18%
MNOV
3.59
+0.01
+0.38%
MRTX
26.51
+2.11
+8.65%
MSTX
0.55
-0.02
-4.01%
NBIX
40.92
-0.35
-0.85%
NUVA
45.21
+0.2
+0.44%
ONCS
0.38
0.00
-0.79%
ONVO
5.72
-0.15
-2.56%
OREX
7.97
-0.52
-6.12%
OTIC
36.1
-0.62
-1.69%
QDEL
26.05
+0.1
+0.39%
RCPT
139.58
+11.58
+9.05%
RGLS
20.96
+2.42
+13.05%
RMD
65.79
+0.95
+1.47%
SCIE
0.03
0.00
-8.28%
SPHS
0.76
-0.05
-6.53%
SRNE
13.61
+0.07
+0.52%
TROV
6.29
-0.05
-0.79%
VICL
1.02
+0.01
+0.99%
VOLC
17.99
0.00
0.00%
ZGNX
1.71
+0.03
+1.79%
Home » Archive by Category

Xconomy

West Coast Biotech Roundup: Pharmacyclics, Gates, Ikaria & More

March 5, 2015 – 3:01 pm

What a week for West Coast news, topped off by AbbVie’s surprise $21 billion grab of Pharmacyclics. It’s the ninth-largest biopharma acquisition of all time, according to one analyst. Any…

[[Click headline to continue reading.]]

With Narrowed Focus, Elcelyx Prepares for Diabetes Drug Trial

March 5, 2015 – 6:30 am

For San Diego’s Elcelyx Therapeutics, 2014 may someday be remembered as “the year of heavy lifting.” Since the fall of 2013, when Elcelyx spun out NaZura BioHealth as a sister company with the same…

[[Click headline to continue reading.]]

“Voice for Everyone”—Life-Sci Women Talk Venture, Pharma Gender Gap

March 4, 2015 – 3:55 pm

By the numbers, the rare-disease drug developer Raptor Pharmaceutical (NASDAQ: RPTP) recently upped its chances of better market performance. That’s because biopharma veteran Julie Anne Smith…

[[Click headline to continue reading.]]

Under New Initiative, Biocom Scouts for Strategic Partners in Japan

March 3, 2015 – 12:40 pm

After working for years to make inroads in China, San Diego’s Biocom industry group has refocused its global partnering efforts on a new initiative intended to connect emerging life sciences…

[[Click headline to continue reading.]]

Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes

March 3, 2015 – 4:30 am

Onesie-twosie? Double dipping? The old razzle dazzle? Whatever you call it, it’s a rare feat to sell a biotech company, hold something back to start a new company, then ride that second horse…

[[Click headline to continue reading.]]

Finistere Raises $150M for New Fund Focused on Agricultural Biotech

March 2, 2015 – 11:01 am

Finistere Ventures, a San Diego investment firm focused on agricultural biotechnology, said it has closed on $150 million for its second fund. In a regulatory filing, the firm indicates plans to…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Flexus, NGM, Illumina, Bob Klein & More

February 26, 2015 – 12:25 pm

A few West Coast companies made news back east this week at the Advances in Genome Biology and Technology conference in Florida, while others (Flexus Biosciences, NGM Biotherapeutics) stayed home to…

[[Click headline to continue reading.]]

Shire Acquires Meritage Pharma in Deal Potentially Worth $245M

February 24, 2015 – 10:01 am

[Updated 2/24/15 6:10 pm. See below.] After acquiring ViroPharma last year in a $4.2 billion deal focused on Cinryze, the Irish pharmaceutical giant Shire says it is following through on a…

[[Click headline to continue reading.]]

Cebix Shuts Down Following Mid-Stage Trial of C-Peptide Drug

February 23, 2015 – 5:40 am

San Diego-based Cebix, which raised about $50 million to advance a C-peptide replacement therapy for treating diabetes-related microvascular problems, has quietly folded its tent. Jacob Fuchs, an…

[[Click headline to continue reading.]]

Innovation Hub: Meet the Science Evangelist

February 20, 2015 – 12:58 pm

Ainissa Ramirez says she’s a “Science Evangelist,” and she travels the country to preach her gospel in classrooms. As a result, the former Yale professor hopes to invigorate…

[[Click headline to continue reading.]]